{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:39:47Z","timestamp":1789886387640,"version":"4.0.1"},"reference-count":446,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.pharmthera.2008.08.009","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T09:27:25Z","timestamp":1220261245000},"page":"292-316","source":"Crossref","is-referenced-by-count":209,"title":["AT2 receptors: Functional relevance in cardiovascular disease"],"prefix":"10.1016","volume":"120","author":[{"given":"Emma S.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2008.08.009_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.HYP.0000228997.88162.a8","article-title":"Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization","volume":"48","author":"Abadir","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib2","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1 receptor antagonist","volume":"276","author":"AbdAlla","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm0901-1003","article-title":"Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness","volume":"7","author":"AbdAlla","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/35024095","article-title":"AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration","volume":"407","author":"AbdAlla","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib5","doi-asserted-by":"crossref","first-page":"R274","DOI":"10.1152\/ajpregu.00439.2005","article-title":"Renin receptor expression in human adipose tissue","volume":"292","author":"Achard","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.HYP.32.3.514","article-title":"Differences in tissue angiotensin II-forming pathways by species and organs in vitro","volume":"32","author":"Akasu","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.2000.2.1.13","article-title":"Inflammation influences vascular remodeling through AT2 receptor expression and signaling","volume":"2","author":"Akishita","year":"2000","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI5182","article-title":"Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth","volume":"103","author":"Akishita","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib9","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.CIR.102.14.1684","article-title":"Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice","volume":"102","author":"Akishita","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib10","doi-asserted-by":"crossref","first-page":"48623","DOI":"10.1074\/jbc.C100512200","article-title":"Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase","volume":"276","author":"Albiston","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/eurheartj\/ehi013","article-title":"The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G\/A) in a cohort of 509 families with premature coronary artery disease","volume":"26","author":"Alfakih","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.HYP.0000128532.28165.77","article-title":"Left ventricle mass index and the common, functional, X-linked angiotensin II type-2 receptor gene polymorphism (-1332 G\/A) in patients with systemic hypertension","volume":"43","author":"Alfakih","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib13","first-page":"S23","article-title":"Localization of angiotensin AT1 and AT2 receptors","volume":"10","author":"Allen","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ki.1997.476","article-title":"Synthesis and effects of active fragments of angiotensin II","volume":"52","author":"Ardaillou","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib15","doi-asserted-by":"crossref","first-page":"F934","DOI":"10.1152\/ajprenal.00145.2002","article-title":"Estrogen upregulates renal angiotensin II AT(2) receptors","volume":"283","author":"Armando","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","article-title":"Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"107","author":"Arnold","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/00004872-200411000-00017","article-title":"Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta","volume":"22","author":"Arun","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.95.5.1193","article-title":"Selective down-regulation of the angiotensin II AT1-receptor subtype in human ventricular myocardium","volume":"95","author":"Asano","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.regpep.2004.06.021","article-title":"Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat","volume":"124","author":"Baiardi","year":"2005","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib20","first-page":"H610","article-title":"Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells","volume":"259","author":"Baker","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.ph.54.030192.001303","article-title":"Cardiac actions of angiotensin II: role of an intracardiac renin\u2013angiotensin system","volume":"54","author":"Baker","year":"1992","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/01.HYP.34.5.1112","article-title":"AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats","volume":"34","author":"Barber","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.HYP.0000241061.51003.b7","article-title":"Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade","volume":"48","author":"Barker","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.99.1.22","article-title":"Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts","volume":"99","author":"Bartunek","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.regpep.2004.12.027","article-title":"Protective effect of the inhibition of the renin\u2013angiotensin system on aging","volume":"128","author":"Basso","year":"2005","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/ATVBAHA.108.164210","article-title":"Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells","volume":"28","author":"Batenburg","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib27","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000128696.12245.57","article-title":"Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries","volume":"109","author":"Batenburg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib28","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.healun.2006.04.012","article-title":"Increased expression of the renin\u2013angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure","volume":"25","author":"Batlle","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/hy09t1.096186","article-title":"Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure","volume":"38","author":"Bautista","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bj3250449","article-title":"Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase","volume":"325","author":"Bedecs","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib31","doi-asserted-by":"crossref","first-page":"H684","DOI":"10.1152\/ajpheart.00632.2005","article-title":"Angiotensin-(1\u20137) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with l-NAME","volume":"290","author":"Benter","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-5793(03)00453-8","article-title":"The \u201bmagic tail\u2019 of G protein-coupled receptors: an anchorage for functional protein networks","volume":"546","author":"Bockaert","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/00004872-200208000-00025","article-title":"Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade","volume":"20","author":"Bonnet","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib34","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.HYP.0000128531.39964.c0","article-title":"Cardiac angiotensin AT2 receptor: what exactly does it do?","volume":"43","author":"Booz","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-291X(92)91629-5","article-title":"The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase","volume":"183","author":"Bottari","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.HYP.26.5.752","article-title":"Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery","volume":"26","author":"Boulanger","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(97)01549-5","article-title":"N- and C-terminal structure\u2013activity study of angiotensin II on the angiotensin AT2 receptor","volume":"343","author":"Bouley","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1081\/JCMR-200053461","article-title":"The angiotensin II type 2 receptor and improved adjacent region function post-MI","volume":"7","author":"Bove","year":"2005","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.HYP.0000115924.94236.91","article-title":"Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling","volume":"43","author":"Bove","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.HYP.0000176744.15592.7d","article-title":"Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries","volume":"46","author":"Brassard","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib41","first-page":"89","article-title":"Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism","volume":"2","author":"Brechler","year":"1994","journal-title":"Recept Channels"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib42","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1161\/hc4601.099401","article-title":"Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor","volume":"104","author":"Brede","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.HYP.0000100445.80029.8E","article-title":"Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice","volume":"42","author":"Brede","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib46","doi-asserted-by":"crossref","first-page":"8D","DOI":"10.1016\/S0002-9149(99)80485-8","article-title":"Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover","volume":"76","author":"Brilla","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3317\/jraas.2005.007","article-title":"Effects of intravenous PD 123319 on haemodynamic and arterial stiffness indices in healthy volunteers","volume":"6","author":"Brillante","year":"2005","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib48","doi-asserted-by":"crossref","unstructured":"Brillante, D. G., O'Sullivan, A. J., Johnston, M. T., & Howes, L. G. (2008). Arterial stiffness and haemodynamic response to vasoactive medications in patients with insulin resistant syndrome. Clin Sci 114, 139\u2212147.","DOI":"10.1042\/CS20070132"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib49","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1006\/jmcc.1996.0168","article-title":"Localization of the angiotensin II receptor subtypes in the human atrium","volume":"28","author":"Brink","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1677\/joe.0.1540355","article-title":"Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats","volume":"154","author":"Brown","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.HYP.0000199912.47657.04","article-title":"Elevated blood pressure and heart rate in human renin receptor transgenic rats","volume":"47","author":"Burckle","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00002512-199710060-00003","article-title":"Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease","volume":"10","author":"Burrell","year":"1997","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9440(10)64571-3","article-title":"Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study","volume":"157","author":"Busche","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib55","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib56","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1440-1681.1996.tb03073.x","article-title":"Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists","volume":"3","author":"Campbell","year":"1996","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00005344-199508000-00009","article-title":"Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme","volume":"26","author":"Campbell","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.HYP.18.6.763","article-title":"Differential regulation of angiotensin peptide levels in plasma and kidney of the rat","volume":"18","author":"Campbell","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib60","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.ASN.0000019409.17099.33","article-title":"Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury","volume":"13","author":"Cao","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.HYP.34.3.408","article-title":"Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy","volume":"34","author":"Cao","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib62","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1046\/j.1523-1755.2000.00427.x","article-title":"Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis","volume":"58","author":"Cao","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib63","first-page":"41","article-title":"Distribution and signal transduction of angiotensin II AT1 and AT2 receptors. Blood pressure","volume":"2","author":"Capponi","year":"1996","journal-title":"Supplement"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib64","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.ATV.15.10.1646","article-title":"Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery","volume":"15","author":"Caputo","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/er.2003-0001","article-title":"Newly recognized components of the renin\u2013angiotensin system: potential roles in cardiovascular and renal regulation","volume":"24","author":"Carey","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib66","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/hy1201.096576","article-title":"Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats","volume":"38","author":"Carey","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(02)00294-X","article-title":"Angiotensin IV interacts with a juxtamembrane site on AT(4)\/IRAP suggesting an allosteric mechanism of enzyme modulation","volume":"113","author":"Caron","year":"2003","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib68","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.HYP.0000175813.04375.8a","article-title":"Evidence for a functional interaction of the angiotensin-(1\u20137) receptor Mas with AT1 and AT2 receptors in the mouse heart","volume":"46","author":"Castro","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib69","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s00018-004-4246-1","article-title":"The angiotensin IV\/AT4 receptor","volume":"61","author":"Chai","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib70","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0026-895X(25)13440-8","article-title":"New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis","volume":"43","author":"Chaki","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/01.STR.0000106480.76217.6F","article-title":"Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history","volume":"35","author":"Chapman","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib72","doi-asserted-by":"crossref","first-page":"L849","DOI":"10.1152\/ajplung.2000.279.5.L849","article-title":"Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release","volume":"279","author":"Chen","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib73","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/ki.1994.458","article-title":"Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus","volume":"46","author":"Cheng","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.HYP.31.2.643","article-title":"Alterations of nitric oxide synthase expression with aging and hypertension in rats","volume":"31","author":"Chou","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib75","first-page":"F264","article-title":"Glomerular angiotensin II receptor subtypes during development of rat kidney","volume":"265","author":"Ciuffo","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0196-9781(97)00291-X","article-title":"Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats","volume":"19","author":"Coleman","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib77","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjhyper.2004.11.007","article-title":"Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists","volume":"18","author":"Cosentino","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib78","doi-asserted-by":"crossref","first-page":"31686","DOI":"10.1074\/jbc.274.44.31686","article-title":"Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum","volume":"274","author":"Cote","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib79","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/eje.0.1360349","article-title":"Extrarenal aspects of angiotensin II function","volume":"136","author":"Csikos","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib81","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1006\/bbrc.2000.4055","article-title":"ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth","volume":"279","author":"Cui","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib82","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.HYP.0000193504.51489.cf","article-title":"The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy","volume":"46","author":"D'Amore","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib83","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib84","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.STR.30.11.2391","article-title":"Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats","volume":"20","author":"Dai","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib85","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2007.11.061","article-title":"Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque","volume":"366","author":"Dandapat","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3317\/jraas.2005.025","article-title":"Renin, prorenin and the putative (pro)renin receptor","volume":"6","author":"Danser","year":"2005","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib87","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00004872-199816060-00017","article-title":"Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans","volume":"16","author":"Danser","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.HYP.24.1.37","article-title":"Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis","volume":"24","author":"Danser","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib89","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tcm.2004.01.002","article-title":"Angiotensin II-mediated development of vascular diseases","volume":"14","author":"Daugherty","year":"2004","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib90","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib91","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","article-title":"Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis","volume":"134","author":"Daugherty","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib92","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","article-title":"Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor","volume":"110","author":"Daugherty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib93","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1074\/jbc.274.24.17058","article-title":"Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor","volume":"274","author":"Daviet","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib94","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib95","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.lfs.2005.09.049","article-title":"Differential effect of losartan in female and male spontaneously hypertensive rats","volume":"78","author":"de P Rodrigues","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.regpep.2004.03.005","article-title":"Angiotensin II and angiotensin-(1\u20137) inhibit the inner cortex Na+-ATPase activity through AT2 receptor","volume":"120","author":"De Souza","year":"2004","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib97","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.HYP.34.4.617","article-title":"In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels","volume":"34","author":"Diep","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib98","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1161\/01.CIR.94.11.2756","article-title":"Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease","volume":"94","author":"Diet","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1152\/physiolgenomics.00312.2005","article-title":"ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR","volume":"27","author":"Diez-Freire","year":"2006","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib100","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0026-895X(25)09488-X","article-title":"Subclasses of angiotensin II binding sites and their functional significance","volume":"38","author":"Dudley","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib102","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.HYP.0000083341.64034.00","article-title":"Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits","volume":"42","author":"Duke","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib103","doi-asserted-by":"crossref","first-page":"H2289","DOI":"10.1152\/ajpheart.01096.2004","article-title":"AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats","volume":"288","author":"Duke","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib104","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sj.bjp.0706036","article-title":"AT(2) receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension","volume":"144","author":"Duke","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib105","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.37.4.1047","article-title":"Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis","volume":"37","author":"Dzau","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib106","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.RES.0000166326.91395.74","article-title":"Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells","volume":"96","author":"Esteban","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1152\/physiolgenomics.00170.2004","article-title":"Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension","volume":"19","author":"Falcon","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib108","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.0000154254.89733.29","article-title":"Angiotensin II type 2 receptor-mediated gene expression profiling in human coronary artery endothelial cells","volume":"45","author":"Falcon","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib109","first-page":"329","article-title":"Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors","volume":"57","author":"Faure","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","article-title":"Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats","volume":"52","author":"Feldman","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib111","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.107.101444","article-title":"Prorenin and renin-induced extracellular signal-regulated kinase 1\/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide","volume":"51","author":"Feldt","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib112","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1681\/ASN.2007091030","article-title":"The putative (pro)renin receptor blocker hrp fails to prevent (pro)renin signaling","volume":"19","author":"Feldt","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib113","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.HYP.0000196268.08909.fb","article-title":"Angiotensin-converting enzyme 2 and angiotensin-(1\u20137): an evolving story in cardiovascular regulation","volume":"47","author":"Ferrario","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib114","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","article-title":"Counterregulatory actions of angiotensin-(1\u20137)","volume":"30","author":"Ferrario","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-0115(98)00134-7","article-title":"Angiotensin-(1\u20137): a bioactive fragment of the renin\u2013angiotensin system","volume":"78","author":"Ferrario","year":"1998","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib116","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib117","doi-asserted-by":"crossref","first-page":"H2281","DOI":"10.1152\/ajpheart.00618.2005","article-title":"Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1\u20137) in regulation of cardiovascular function","volume":"289","author":"Ferrario","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib118","doi-asserted-by":"crossref","first-page":"H1113","DOI":"10.1152\/ajpheart.00828.2006","article-title":"The nonpeptide angiotensin-(1\u20137) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction","volume":"292","author":"Ferreira","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib119","first-page":"H906","article-title":"Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes","volume":"275","author":"Fischer","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.HYP.35.1.353","article-title":"Angiotensin-converting enzyme expression in human carotid artery atherosclerosis","volume":"35","author":"Fukuhara","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(98)01675-5","article-title":"AT2 receptor stimulation induces generation of ceramides in PC12W cells","volume":"443","author":"Gallinat","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib122","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1016\/j.bmc.2006.05.019","article-title":"Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity","volume":"14","author":"Georgsson","year":"2006","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib123","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/jm0613469","article-title":"Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor","volume":"50","author":"Georgsson","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib124","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1021\/jm050280z","article-title":"Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity","volume":"48","author":"Georgsson","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/00004872-199816121-00027","article-title":"Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats","volume":"16","author":"Gigante","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1464-5491.2003.00979.x","article-title":"The renin\u2013angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations","volume":"20","author":"Gilbert","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib127","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/08037050310031017","article-title":"Increase in systemic blood pressure during intra-arterial PD123319 infusion: evidence for functional expression of angiotensin type 2 receptors in normal volunteers","volume":"13","author":"Gilles","year":"2004","journal-title":"Blood Press"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.HYP.31.1.349","article-title":"AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism","volume":"31","author":"Gohlke","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-2-19","article-title":"ACE2 gene expression is up-regulated in the human failing heart","volume":"2","author":"Goulter","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0169-328X(02)00101-8","article-title":"Angiotensin protects cortical neurons from hypoxic-induced apoptosis via the angiotensin type 2 receptor","volume":"99","author":"Grammatopoulos","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pharmtox.36.1.281","article-title":"Angiotensin receptors and their therapeutic implications","volume":"36","author":"Griendling","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib132","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2008.08.009_bib133","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1\u20137)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib134","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","article-title":"Chronic angiotensin-(1\u20137) prevents cardiac fibrosis in DOCA-salt model of hypertension","volume":"290","author":"Grobe","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00004872-200018070-00018","article-title":"Long-term blood pressure telemetry in AT2 receptor-disrupted mice","volume":"18","author":"Gross","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib136","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1523-1755.2000.00820.x","article-title":"Inhibition of pressure natriuresis in mice lacking the AT2 receptor","volume":"57","author":"Gross","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib137","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00004872-200405000-00023","article-title":"Cardiac hypertrophy and fibrosis in chronic l-NAME-treated AT2 receptor-deficient mice","volume":"22","author":"Gross","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib138","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00004872-200311000-00028","article-title":"Chronic pretreatment with candersartan improves recovery from focal cerebral ischemia in rats","volume":"21","author":"Groth","year":"2003","journal-title":"J Hypertens."},{"key":"10.1016\/j.pharmthera.2008.08.009_bib139","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbrc.2003.09.154","article-title":"Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane","volume":"310","author":"Guo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib140","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/01.hjh.0000226200.73065.5d","article-title":"Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade","volume":"24","author":"Guo","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib141","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J Clin Invest"},{"issue":"III","key":"10.1016\/j.pharmthera.2008.08.009_bib142","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/clc.4960181507","article-title":"Angiotensin receptors: physiology and pharmacology","volume":"18","author":"Guthrie","year":"1995","journal-title":"Clin Cardiol"},{"issue":"Suppl 11","key":"10.1016\/j.pharmthera.2008.08.009_bib143","first-page":"S69","article-title":"Renal proximal tubular AT2 receptor: signaling and transport","volume":"10","author":"Haithcock","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib144","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.0000151622.47814.6f","article-title":"Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis\/diuresis in obese Zucker rats","volume":"45","author":"Hakam","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib145","doi-asserted-by":"crossref","first-page":"F1430","DOI":"10.1152\/ajprenal.00218.2005","article-title":"Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO\/cGMP-dependent pathway","volume":"290","author":"Hakam","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib146","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/01.HYP.0000220112.91724.fc","article-title":"Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats","volume":"47","author":"Hakam","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib147","doi-asserted-by":"crossref","first-page":"F503","DOI":"10.1152\/ajprenal.00092.2005","article-title":"Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats","volume":"290","author":"Hakam","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib149","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bjp.0705484","article-title":"Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide","volume":"140","author":"Hannan","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11906-004-0086-5","article-title":"Vascular angiotensin II actions mediated by angiotensin II type 2 receptors","volume":"6","author":"Hannan","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib151","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.RES.87.9.753","article-title":"Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation","volume":"87","author":"Hansen","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib152","doi-asserted-by":"crossref","first-page":"F516","DOI":"10.1152\/ajprenal.00294.2003","article-title":"Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model","volume":"286","author":"Hashimoto","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib153","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/01.CIR.95.5.1201","article-title":"AT1 and AT2 angiotensin receptor gene expression in human heart failure","volume":"95","author":"Haywood","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib154","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/377744a0","article-title":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice","volume":"377","author":"Hein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib155","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1210\/me.11.9.1266","article-title":"Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand","volume":"11","author":"Hein","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib156","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.HYP.37.1.72","article-title":"Angiotensin-(1\u20137)-stimulated nitric oxide and superoxide release from endothelial cells","volume":"37","author":"Heitsch","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib157","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/hy1101.096109","article-title":"Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation","volume":"38","author":"Henrion","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib158","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1210\/en.2003-1615","article-title":"Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice","volume":"145","author":"Henriques","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib159","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/en.139.5.2579","article-title":"Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes","volume":"139","author":"Heymes","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib160","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.90.3.1328","article-title":"Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats","volume":"90","author":"Heymes","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib161","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1681\/ASN.V103481","article-title":"Angiotensin II-stimulated nitric oxide release from porcine pulmonary endothelium is mediated by angiotensin IV","volume":"10","author":"Hill-Kapturczak","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib162","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.HYP.0000164571.77710.19","article-title":"Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension","volume":"45","author":"Hiyoshi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib163","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.HYP.0000128022.24598.4f","article-title":"Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding","volume":"43","author":"Hiyoshi","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib164","doi-asserted-by":"crossref","first-page":"19022","DOI":"10.1074\/jbc.272.30.19022","article-title":"Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis","volume":"272","author":"Horiuchi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib165","doi-asserted-by":"crossref","unstructured":"Hu, C., Dandapat, A., Chen, J., Liu, Y., Hermonat, P. L., Carey, R. M., et al. (2008). Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis 199, 288\u2212294.","DOI":"10.1016\/j.atherosclerosis.2007.11.006"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib166","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.ki.5000011","article-title":"Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms","volume":"69","author":"Huang","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib167","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib168","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1172\/JCI21398","article-title":"Inhibition of diabetic nephropathy by a decoy peptide corresponding to the \u201chandle\u201d region for nonproteolytic activation of prorenin","volume":"114","author":"Ichihara","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib169","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.HYP.0000215838.48170.0b","article-title":"Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension","volume":"47","author":"Ichihara","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib171","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/01.CIR.0000033826.52681.37","article-title":"Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction","volume":"106","author":"Ichihara","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib172","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/377748a0","article-title":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor","volume":"377","author":"Ichiki","year":"1995","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.pharmthera.2008.08.009_bib173","doi-asserted-by":"crossref","first-page":"H3372","DOI":"10.1152\/ajpheart.00997.2007","article-title":"Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling","volume":"293","author":"Isbell","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib174","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib175","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/01.STR.0000027274.03779.F3","article-title":"Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist","volume":"33","author":"Ito","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib176","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIRCULATIONAHA.104.525550","article-title":"Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice","volume":"112","author":"Iwai","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib177","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib178","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.HYP.28.4.663","article-title":"Angiotensin II type 2 receptor subtype mediates phospholipase A2-dependent signaling in rabbit proximal tubular epithelial cells","volume":"28","author":"Jacobs","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib179","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-3565(25)38196-6","article-title":"Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved","volume":"265","author":"Jaiswal","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00004872-199715060-00011","article-title":"Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats","volume":"15","author":"Jandeleit-Dahm","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib181","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.HYP.0000177436.09733.d4","article-title":"Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight\/time-of-flight mass analysis","volume":"46","author":"Jankowski","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib182","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2550","article-title":"Aliskiren: the first renin inhibitor for clinical treatment","volume":"7","author":"Jensen","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib183","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000016179.52601.B4","article-title":"Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells","volume":"39","author":"Jin","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib184","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.HYP.0000123574.60586.7d","article-title":"Renal interstitial guanosine cyclic 3\u2032, 5\u2032-monophosphate mediates pressure\u2013natriuresis via protein kinase G","volume":"43","author":"Jin","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.HYP.38.3.309","article-title":"Renal interstitial cGMP mediates natriuresis by direct tubule mechanism","volume":"38","author":"Jin","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib186","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1021\/jm049651m","article-title":"AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics","volume":"47","author":"Johannesson","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib187","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.hjh.0000174078.95745.77","article-title":"Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE\u2212\/\u2212 mice","volume":"23","author":"Johansson","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib188","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00004872-199212007-00002","article-title":"Franz Volhard Lecture. Renin\u2013angiotensin system: a dual tissue and hormonal system for cardiovascular control","volume":"10","author":"Johnston","year":"1992","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib189","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.yjmcc.2004.08.004","article-title":"Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade","volume":"37","author":"Jones","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib190","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib191","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1681\/ASN.V461337","article-title":"The renin\u2013angiotensin system in streptozotocin-induced diabetes mellitus in the rat","volume":"4","author":"Kalinyak","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib192","doi-asserted-by":"crossref","first-page":"C1389","DOI":"10.1152\/ajpcell.1994.267.5.C1389","article-title":"Angiotensin II type 2 receptor stimulation of neuronal K+ currents involves an inhibitory GTP binding protein","volume":"267","author":"Kang","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib193","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08037050310001057","article-title":"Angiotensin AT1\/AT2 receptors: regulation, signalling and function","volume":"12","author":"Kaschina","year":"2003","journal-title":"Blood Press"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib194","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmcc.1997.0376","article-title":"Cultured myofibroblasts generate angiotensin peptides de novo","volume":"29","author":"Katwa","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib195","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","article-title":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients","volume":"97","author":"Keidar","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib196","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib197","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.79.4.887","article-title":"Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes","volume":"79","author":"Kijima","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib198","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1189\/jlb.1204715","article-title":"Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture","volume":"78","author":"Kim","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib199","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.92.1.88","article-title":"Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery","volume":"92","author":"Kim","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib200","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/01.hjh.0000174611.49274.1e","article-title":"Does the AT2-receptor mediate anti-atherosclerotic actions?","volume":"23","author":"Kintscher","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib201","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/HYPERTENSIONAHA.107.087130","article-title":"Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis","volume":"49","author":"Kokje","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib202","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-0115(96)02116-7","article-title":"Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes","volume":"68","author":"Kramar","year":"1997","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib204","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1159\/000076749","article-title":"Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney","volume":"96","author":"Kumar","year":"2004","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.HYP.0000050101.90932.14","article-title":"Cardiac Angiotensin II Type 2 receptor activates the kinin\/NO system and inhibits fibrosis","volume":"41","author":"Kurisu","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib206","doi-asserted-by":"crossref","first-page":"22729","DOI":"10.1074\/jbc.271.37.22729","article-title":"Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells","volume":"271","author":"Laflamme","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib207","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib208","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.0000093193.63314.D9","article-title":"Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart","volume":"108","author":"Lako-Futo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib209","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BJ20051455","article-title":"Involvement of the Gi\/o\/cGMP\/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1\u20137)","volume":"395","author":"Lara Lda","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib211","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.102.045492","article-title":"Structure\u2013activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase","volume":"305","author":"Lee","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib212","doi-asserted-by":"crossref","first-page":"16901","DOI":"10.1074\/jbc.274.24.16901","article-title":"Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis","volume":"274","author":"Lehtonen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib213","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.fjc.0000175237.41573.63","article-title":"The endothelium-dependent vasodilator effect of the nonpeptide Ang(1\u20137) mimic AVE 0991 is abolished in the aorta of mas-knockout mice","volume":"46","author":"Lemos","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib214","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/joe.0.1530269","article-title":"Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents","volume":"153","author":"Leung","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib215","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib216","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1471-4159.2003.01852.x","article-title":"Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP)","volume":"86","author":"Lew","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib217","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib218","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10557-005-0443-x","article-title":"Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression","volume":"19","author":"Li","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2008.08.009_bib219","doi-asserted-by":"crossref","first-page":"H727","DOI":"10.1152\/ajpheart.00938.2006","article-title":"Potentiation of the antihypertensive action of losartan by peripheral over expression of the angiotensin II (Ang II) type 2 receptor","volume":"292","author":"Li","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib220","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury","volume":"10","author":"Li","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib221","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib222","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bjp.0705838","article-title":"AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR","volume":"142","author":"Li","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib223","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1358\/mf.2003.25.2.723680","article-title":"Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts","volume":"25","author":"Lijnen","year":"2003","journal-title":"Methods Findings Exp Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib224","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1358\/mf.2000.22.10.802287","article-title":"Induction of cardiac fibrosis by angiotensin II","volume":"22","author":"Lijnen","year":"2000","journal-title":"Methods Findings Exp Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib225","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI119360","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors","volume":"99","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib226","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1016\/S0021-9258(17)37619-6","article-title":"Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells","volume":"269","author":"Lokuta","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib227","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.CIR.0000013847.07035.B9","article-title":"Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats","volume":"105","author":"Loot","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib228","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1091\/mbc.E03-06-0383","article-title":"The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling","volume":"14","author":"Lopez-Ilasaca","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib229","first-page":"H844","article-title":"Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts","volume":"267","author":"Lopez","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib230","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1681\/ASN.V1351162","article-title":"Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice","volume":"13","author":"Lorenzo","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib231","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(24)35142-0","article-title":"Functional evidence for an angiotensin IV receptor in rat resistance arteries","volume":"291","author":"Loufrani","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib232","first-page":"984","article-title":"Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice","volume":"118","author":"Lu","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib233","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/01.wnr.0000187636.13147.cd","article-title":"Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats","volume":"16","author":"Lu","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib234","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s000180050490","article-title":"Beyond blood pressure: new roles for angiotensin II","volume":"56","author":"Lucius","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib235","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.188.4.661","article-title":"The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats","volume":"188","author":"Lucius","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib236","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1523-1755.1998.00893.x","article-title":"Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction","volume":"53","author":"Ma","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib237","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI1885","article-title":"Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects","volume":"101","author":"Masaki","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib238","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.bjp.0703371","article-title":"Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats","volume":"130","author":"Matrougui","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib239","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.HYP.34.4.659","article-title":"Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries","volume":"34","author":"Matrougui","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000045121","article-title":"Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization","volume":"80","author":"Matsubara","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib241","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.HYP.0000127563.14064.fd","article-title":"Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer","volume":"43","author":"Metcalfe","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib242","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1046\/j.1523-1755.64.s86.12.x","article-title":"Renin\u2013angiotensin system activation and interstitial inflammation in human diabetic nephropathy","author":"Mezzano","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib243","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/CEH-100102664","article-title":"Examination of angiotensin II type 1 and type 2 receptor expression in human kidneys by immunohistochemistry","volume":"23","author":"Mifune","year":"2001","journal-title":"Clin Exp Hypertens (NY)"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib244","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.HYP.36.5.845","article-title":"Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells","volume":"36","author":"Mifune","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/en.2003-0673","article-title":"Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes","volume":"145","author":"Min","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib246","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1093\/emboj\/19.15.4026","article-title":"Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis","volume":"19","author":"Miura","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib247","doi-asserted-by":"crossref","first-page":"18237","DOI":"10.1074\/jbc.M500639200","article-title":"Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation","volume":"280","author":"Miura","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib248","first-page":"F437","article-title":"Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney","volume":"277","author":"Miyata","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib249","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(99)00047-6","article-title":"Up regulation of AT4 receptor levels in carotid arteries following balloon injury","volume":"83","author":"Moeller","year":"1999","journal-title":"Regulatory Pept"},{"issue":"12","key":"10.1016\/j.pharmthera.2008.08.009_bib250","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1161\/ATVBAHA.107.144154","article-title":"Emerging concepts of regulation of angiotensin II receptors. new players and targets for traditional receptors","volume":"27","author":"Mogi","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib251","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.HYP.0000229648.67883.f9","article-title":"Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2","volume":"48","author":"Mogi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib252","first-page":"F39","article-title":"Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis","volume":"276","author":"Morrissey","year":"1999","journal-title":"Am J Physiol"},{"issue":"Suppl 11","key":"10.1016\/j.pharmthera.2008.08.009_bib253","first-page":"S248","article-title":"Candesartan: a new-generation angiotensin II AT1 receptor blocker: pharmacology, antihypertensive efficacy, renal function, and renoprotection","volume":"10","author":"Morsing","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib254","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0303-7207(95)03586-V","article-title":"Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells","volume":"112","author":"Mukoyama","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.RES.82.1.13","article-title":"Local angiotensin II generation in the rat heart: role of renin uptake","volume":"82","author":"Muller","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib256","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/HYPERTENSIONAHA.107.101493","article-title":"(Pro)renin receptor peptide inhibitor \u201chandle-region\u201d peptide does not affect hypertensive nephrosclerosis in Goldblatt rats","volume":"51","author":"Muller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib257","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/01.HYP.27.3.760","article-title":"Opposing actions of angiotensin II on microvascular growth and arterial blood pressure","volume":"27","author":"Munzenmaier","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib258","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(24)37208-8","article-title":"Signal transduction mechanisms involved in angiotensin-(1\u20137)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells","volume":"284","author":"Muthalif","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib259","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/bj3060087","article-title":"Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells","volume":"306","author":"Nahmias","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib447","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.92.23.10663","article-title":"The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer","volume":"92","author":"Nakajima","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib260","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.ki.5000265","article-title":"Renin\/prorenin receptors","volume":"69","author":"Nguyen","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib261","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib262","first-page":"285","article-title":"Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia","volume":"2","author":"Nickenig","year":"1997","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib263","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI117675","article-title":"Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction","volume":"95","author":"Nio","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib264","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1097-2765(00)80169-0","article-title":"Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men","volume":"3","author":"Nishimura","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib265","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.31.10.2478","article-title":"Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats","volume":"31","author":"Nishimura","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib266","first-page":"H1395","article-title":"Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle","volume":"275","author":"Nora","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib267","doi-asserted-by":"crossref","first-page":"28989","DOI":"10.1074\/jbc.M403880200","article-title":"Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP","volume":"279","author":"Nouet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib268","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.108.110932","article-title":"Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine","volume":"51","author":"Nussberger","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib269","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1161\/01.CIR.96.11.3954","article-title":"Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism","volume":"96","author":"Ohkubo","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib270","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.HYP.0000048340.53100.43","article-title":"Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling","volume":"41","author":"Oishi","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib271","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.HYP.0000178564.14464.80","article-title":"Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression","volume":"46","author":"Okumura","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib272","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2006.10.001","article-title":"Type 1 angiotensin receptor pharmacology: signaling beyond G proteins","volume":"113","author":"Oro","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib273","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/01.HYP.30.5.1238","article-title":"Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney","volume":"30","author":"Ozono","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib274","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.HYP.0000196950.48596.21","article-title":"Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat","volume":"47","author":"Padia","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/HYPERTENSIONAHA.107.103242","article-title":"Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats","volume":"51","author":"Padia","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib276","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000254833.85106.4d","article-title":"Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats","volume":"49","author":"Padia","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib277","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.HYP.32.3.452","article-title":"Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression","volume":"32","author":"Parker","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib278","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib279","first-page":"L1061","article-title":"Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation","volume":"275","author":"Patel","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib280","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin\u2013angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib281","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1440-1681.2001.03511.x","article-title":"Role of angiotensin type 2 receptors in human forearm vascular responses of normal volunteers","volume":"28","author":"Phoon","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib282","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3317\/jraas.2002.006","article-title":"Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)-receptors","volume":"3","author":"Phoon","year":"2002","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib283","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.HYP.0000179573.91016.3f","article-title":"Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.[see comment]","volume":"46","author":"Pilz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib284","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.106.085035","article-title":"Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats","volume":"50","author":"Pinaud","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib285","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.HYP.0000141438.64887.42","article-title":"Nonpeptide AVE 0991 is an angiotensin-(1\u20137) receptor Mas agonist in the mouse kidney","volume":"44","author":"Pinheiro","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib286","doi-asserted-by":"crossref","first-page":"C214","DOI":"10.1152\/ajpcell.1998.274.1.C214","article-title":"Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells","volume":"274","author":"Pueyo","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib287","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1681\/ASN.V102245","article-title":"Angiotensin II stimulates the synthesis and secretion of vascular permeability factor\/vascular endothelial growth factor in human mesangial cells","volume":"10","author":"Pupilli","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib288","doi-asserted-by":"crossref","first-page":"R1669","DOI":"10.1152\/ajpregu.00183.2006","article-title":"ANG II type 2 receptors and neural control of intrarenal blood flow","volume":"291","author":"Rajapakse","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib289","doi-asserted-by":"crossref","first-page":"R745","DOI":"10.1152\/ajpregu.00477.2004","article-title":"Angiotensin II and nitric oxide in neural control of intrarenal blood flow","volume":"289","author":"Rajapakse","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1043-2760(01)00381-2","article-title":"Angiotensin III: a central regulator of vasopressin release and blood pressure","volume":"12","author":"Reaux","year":"2001","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib291","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrd2032","article-title":"Therapeutic implications of the gender-specific aspects of cardiovascular disease","volume":"5","author":"Regitz-Zagrosek","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib292","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.91.5.1461","article-title":"Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts","volume":"91","author":"Regitz-Zagrosek","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib293","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1096\/fj.02-1193fje","article-title":"Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kB","volume":"17","author":"Reinecke","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib294","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.HYP.0000193498.07087.83","article-title":"The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous","volume":"46","author":"Reudelhuber","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib295","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000209020.69734.73","article-title":"A place in our hearts for the lowly angiotensin 1\u20137 peptide?","volume":"47","author":"Reudelhuber","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib296","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib297","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1161\/01.CIR.90.6.2772","article-title":"Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis","volume":"90","author":"Rihal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib298","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004872-200501000-00026","article-title":"Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin\u2013angiotensin system","volume":"23","author":"Rizkalla","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib299","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1097\/01.ASN.0000099374.58607.C9","article-title":"Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors","volume":"14","author":"Rizkalla","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib300","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/oxfordjournals.eurheartj.a015008","article-title":"Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction","volume":"17","author":"Rogg","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib301","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1399-3011.2004.00184.x","article-title":"Synthesis and AT2 receptor-binding properties of angiotensin II analogues","volume":"64","author":"Rosenstrom","year":"2004","journal-title":"J Pept Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib302","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1021\/jm0491492","article-title":"New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4\u20135 of angiotensin II act as agonists","volume":"48","author":"Rosenstrom","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib303","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0006-8993(03)02231-5","article-title":"Localization of AT(2) receptors in the nucleus of the solitary tract of spontaneously hypertensive and Wistar Kyoto rats using [125I] CGP42112: upregulation of a non-angiotensin II binding site following unilateral nodose ganglionectomy","volume":"968","author":"Roulston","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib304","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0167-0115(95)00010-9","article-title":"Angiotensin-(1\u20137) binding at angiotensin II receptors in the rat brain","volume":"56","author":"Rowe","year":"1995","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib305","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1046\/j.1523-1755.64.s86.5.x","article-title":"Renal expression of angiotensin type 2 (AT2) receptors during kidney damage","author":"Ruiz-Ortega","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib306","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10571-006-9009-0","article-title":"Mechanisms of the anti-ischemic effect of angiotensin II AT(1) receptor antagonists in the brain","volume":"26","author":"Saavedra","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib307","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1291\/hypres.19.201","article-title":"Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors","volume":"19","author":"Saito","year":"1996","journal-title":"Hypertens Res Clin Exp"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib308","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1161\/CIRCULATIONAHA.105.541714","article-title":"Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution","volume":"112","author":"Sales","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.0000251881.89610.ee","article-title":"Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism","volume":"49","author":"Salomone","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib310","doi-asserted-by":"crossref","unstructured":"Sampson, A. K., Moritz, K. M., Jones, E. S., Flower, R. L., Widdop, R. E., & Denton, K. M. (2008). Enhanced AT2R-vasodilator mechanisms mediate Ang II-induced decreases in arterial pressure in female rats. Hypertension 52, 666\u2212671.","DOI":"10.1161\/HYPERTENSIONAHA.108.114058"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib311","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MNH.0b013e328031f362","article-title":"Angiotensin-(1\u20137) and the renin\u2013angiotensin system","volume":"16","author":"Santos","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib312","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(00)00138-5","article-title":"Angiotensin-(1\u20137): an update","volume":"91","author":"Santos","year":"2000","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib313","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.HYP.0000215289.51180.5c","article-title":"Impairment of in vitro and in vivo heart function in angiotensin-(1\u20137) receptor MAS knockout mice","volume":"47","author":"Santos","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib314","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib315","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0196-9781(94)90115-5","article-title":"AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues","volume":"15","author":"Sardinia","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib316","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9440(10)63448-7","article-title":"Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin","volume":"163","author":"Sarlos","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib317","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1097\/01.hjh.0000251902.85675.7e","article-title":"Angiotensin II\/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase","volume":"24","author":"Savoia","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib318","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.hjh.0000166845.49850.39","article-title":"Negative regulation of RhoA\/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats","volume":"23","author":"Savoia","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib319","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000253968.95136.b8","article-title":"Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients","author":"Savoia","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/01.HYP.0000253968.95136.b8","article-title":"Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients","volume":"49","author":"Savoia","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib321","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.0000251700.00994.0d","article-title":"A novel signal transduction cascade involving direct physical interaction of the renin\/prorenin receptor with the transcription factor promyelocytic zinc finger protein","volume":"99","author":"Schefe","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib322","first-page":"R917","article-title":"Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin","volume":"264","author":"Scheuer","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib323","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0735-1097(00)01063-9","article-title":"Effect of the angiotensin II type 2-receptor gene (+1675 G\/A) on left ventricular structure in humans","volume":"37","author":"Schmieder","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib324","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS study. Evaluation of acute candesartan cilexetil therapy in stroke survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib325","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib326","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2337\/diabetes.43.10.1180","article-title":"The cardiac renin\u2013angiotensin system in STZ-induced diabetes","volume":"43","author":"Sechi","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib327","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI10037","article-title":"Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload","volume":"106","author":"Senbonmatsu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib328","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1093\/emboj\/cdg637","article-title":"A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy","volume":"22","author":"Senbonmatsu","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib329","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib330","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/01.HYP.26.1.164","article-title":"Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation","volume":"26","author":"Seyedi","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib331","first-page":"F922","article-title":"Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland","volume":"268","author":"Shanmugam","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib332","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/en.140.1.500","article-title":"Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain","volume":"140","author":"Shenoy","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib333","first-page":"83","article-title":"Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure","volume":"51","author":"Shibasaki","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib334","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(25)38306-0","article-title":"Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+\/\u2212)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)","volume":"266","author":"Shibouta","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.HYP.20.2.168","article-title":"Increase of angiotensin converting enzyme gene expression in the hypertensive aorta","volume":"20","author":"Shiota","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib336","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0306-3623(00)00078-1","article-title":"Sexual dimorphism in the response of thoracic aorta from SHRs to losartan","volume":"34","author":"Silva-Antonialli","year":"2000","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib337","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cardiores.2004.01.020","article-title":"A lower ratio of AT1\/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats","volume":"62","author":"Silva-Antonialli","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib338","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.HYP.32.4.654","article-title":"Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure, and time","volume":"32","author":"Simon","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib339","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI118630","article-title":"The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3\u2032, 5\u2032-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats","volume":"97","author":"Siragy","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib340","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1172\/JCI119531","article-title":"The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats","volume":"100","author":"Siragy","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib341","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/01.HYP.33.5.1237","article-title":"Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model","volume":"33","author":"Siragy","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib342","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.HYP.35.5.1074","article-title":"Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats","volume":"35","author":"Siragy","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib343","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.HYP.38.2.183","article-title":"Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP","volume":"38","author":"Siragy","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib344","doi-asserted-by":"crossref","first-page":"R1461","DOI":"10.1152\/ajpregu.00014.2007","article-title":"NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats","volume":"293","author":"Siragy","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib345","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.96.11.6506","article-title":"Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor","volume":"96","author":"Siragy","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib346","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjp.0703566","article-title":"Differential role of angiotensin II receptor subtypes on endothelial superoxide formation","volume":"131","author":"Sohn","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib347","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","article-title":"The AT2 receptor\u2014a matter of love and hate","volume":"26","author":"Steckelings","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib348","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI117710","article-title":"The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells","volume":"95","author":"Stoll","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib349","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","article-title":"Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox","volume":"114","author":"Strauss","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.HYP.33.1.207","article-title":"Angiotensin-(1\u20137) reduces smooth muscle growth after vascular injury","volume":"33","author":"Strawn","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib351","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0169-328X(97)00298-2","article-title":"Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor","volume":"53","author":"Stroth","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib352","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.HYP.0000042096.17141.B1","article-title":"Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR","volume":"40","author":"Su","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib353","first-page":"325","article-title":"Candesartan reduces superoxide production after global cerebral ischemia","volume":"16","author":"Sugawara","year":"2005","journal-title":"Neuropharmacol Neurotox"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib354","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/01.HYP.37.6.1394","article-title":"Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice","volume":"37","author":"Sugino","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib355","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.CIR.0000024103.04821.86","article-title":"Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib356","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.RES.73.3.439","article-title":"Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy","volume":"73","author":"Suzuki","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib357","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0167-0115(92)90527-2","article-title":"Discovery of a distinct binding site for angiotensin II (3\u20138), a putative angiotensin IV receptor","volume":"40","author":"Swanson","year":"1992","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib358","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib359","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.LAB.0000017372.76297.EB","article-title":"Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways","volume":"82","author":"Tamarat","year":"2002","journal-title":"Lab Investig"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib360","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.HYP.35.5.1069","article-title":"Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo","volume":"35","author":"Tea","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib361","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0002-9440(10)63740-6","article-title":"Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells","volume":"164","author":"Tejera","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib362","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(98)00140-2","article-title":"Regulation of angiotensin II type 1 (AT1) receptor function","volume":"79","author":"Thomas","year":"1999","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib363","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/01.hjh.0000220416.07235.37","article-title":"Angiotensin receptor blockers and cerebral protection in stroke","volume":"24","author":"Thone-Reineke","year":"2006","journal-title":"J Hypertens Suppl"},{"issue":"Suppl 11","key":"10.1016\/j.pharmthera.2008.08.009_bib364","first-page":"S220","article-title":"AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries","volume":"10","author":"Thorup","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib365","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s004240050535","article-title":"Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries","volume":"435","author":"Thorup","year":"1998","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib366","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-6147(91)90498-H","article-title":"Nonpeptide angiotensin II receptor antagonists","volume":"12","author":"Timmermans","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib367","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)00446-6","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists","volume":"45","author":"Timmermans","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib368","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib369","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1590\/S0100-879X2002000900001","article-title":"Recent advances in angiotensin II signaling","volume":"35","author":"Touyz","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib370","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.HYP.33.1.366","article-title":"Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR","volume":"33","author":"Touyz","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib371","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.HYP.37.2.574","article-title":"p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY","volume":"37","author":"Touyz","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib372","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1440-1681.2003.03930.x","article-title":"Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension","volume":"30","author":"Touyz","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib373","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.ki.5000130","article-title":"Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules","volume":"69","author":"Tsurumi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib374","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI7886","article-title":"Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation","volume":"104","author":"Tsutsumi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib375","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.83.10.1035","article-title":"Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression","volume":"83","author":"Tsutsumi","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib376","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.105.594978","article-title":"Angiotensin receptor blockers do not increase risk of myocardial infarction","volume":"114","author":"Tsuyuki","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib377","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.HYP.28.5.916","article-title":"Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase","volume":"28","author":"Tsuzuki","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib378","first-page":"S95","article-title":"Angiotensin receptors","volume":"14","author":"Unger","year":"1996","journal-title":"J Hypertens Supplement"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib379","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.HYP.37.6.1399","article-title":"Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors","volume":"37","author":"Varagic","year":"2001","journal-title":"Hypertension."},{"key":"10.1016\/j.pharmthera.2008.08.009_bib380","doi-asserted-by":"crossref","first-page":"F207","DOI":"10.1152\/ajprenal.00216.2004","article-title":"Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation","volume":"288","author":"Vazquez","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib381","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/bmj.329.7477.1248","article-title":"Angiotensin receptor blockers and myocardial infarction","volume":"329","author":"Verma","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib382","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib383","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1161\/01.STR.0000190002.79052.bf","article-title":"Constrictor and dilator effects of angiotensin II on cerebral arterioles","volume":"36","author":"Vincent","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib386","doi-asserted-by":"crossref","unstructured":"Vinh, A., Widdop, R. E., Drummond, G. R., & Gaspari, T. A. (2008a). Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. Cardiovasc Res 77, 178\u2212187.","DOI":"10.1093\/cvr\/cvm021"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib385","doi-asserted-by":"crossref","unstructured":"Vinh, A., Widdop, R. E., Chai, S. Y., & Gaspari, T. A. (2008b). Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma. Atherosclerosis 200, 37\u221244.","DOI":"10.1016\/j.atherosclerosis.2007.12.042"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib387","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib388","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0196-9781(92)90187-8","article-title":"Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing","volume":"13","author":"Viswanathan","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib389","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1172\/JCI116043","article-title":"Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta","volume":"90","author":"Viswanathan","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib390","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0167-0115(01)00258-0","article-title":"Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures of mice","volume":"99","author":"Von Bohlen und Halbach","year":"2001","journal-title":"Regulatory Pept"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib391","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.106.664854","article-title":"C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice","volume":"115","author":"Vongpatanasin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib392","doi-asserted-by":"crossref","first-page":"H1004","DOI":"10.1152\/ajpheart.00886.2005","article-title":"Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling","volume":"290","author":"Voros","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib393","first-page":"443","article-title":"Angiotensin III acts as a vasodepressor agent via AT2R","volume":"42","author":"Walters","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib394","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.HYP.0000160325.59323.b8","article-title":"Angiotensin-(1\u20137) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats","volume":"45","author":"Walters","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib395","first-page":"169","article-title":"Ischemic injury in experimental stroke depends on angiotensin II","volume":"16","author":"Walther","year":"2002","journal-title":"Stroke."},{"key":"10.1016\/j.pharmthera.2008.08.009_bib396","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/jm031031i","article-title":"First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo","volume":"47","author":"Wan","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib397","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib398","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1113\/expphysiol.2004.027359","article-title":"Elevated blood pressure in normotensive rats produced by \u201bknockdown\u2019 of the angiotensin type 2 receptor","volume":"89","author":"Wang","year":"2004","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib399","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/01.HYP.0000073843.56046.45","article-title":"Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates","volume":"41","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib400","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.HYP.33.1.96","article-title":"Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension","volume":"33","author":"Wang","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib401","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s001090100243","article-title":"Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1\/ERK2 activity, but inhibits protein tyrosine phosphatases","volume":"79","author":"Warnecke","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib402","doi-asserted-by":"crossref","first-page":"R1729","DOI":"10.1152\/ajpregu.00385.2005","article-title":"Intronic ANG II type 2 receptor gene polymorphism 1675 G\/A modulates receptor protein expression but not mRNA splicing","volume":"289","author":"Warnecke","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib403","doi-asserted-by":"crossref","first-page":"39353","DOI":"10.1074\/jbc.M508914200","article-title":"Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells","volume":"280","author":"Warner","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib404","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/01.CIR.99.15.2027","article-title":"Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin\u2013angiotensin system","volume":"99","author":"Warnholtz","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib405","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","article-title":"Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice","volume":"110","author":"Wassmann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib406","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","article-title":"Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib407","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1357-2725(96)00116-1","article-title":"Myofibroblasts and local angiotensin II in rat cardiac tissue repair","volume":"29","author":"Weber","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib408","doi-asserted-by":"crossref","first-page":"F254","DOI":"10.1152\/ajprenal.2001.280.2.F254","article-title":"Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors","volume":"280","author":"Wehbi","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib409","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1152\/ajpendo.00752.2007","article-title":"Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat","volume":"295","author":"Whaley-Connell","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib410","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(24)37201-5","article-title":"Differential distribution of angiotensin AT2 receptors in the normal and failing human heart","volume":"284","author":"Wharton","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib411","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1046\/j.1460-9568.1999.00787.x","article-title":"Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat","volume":"11","author":"Wheeler-Schilling","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib412","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0006-291X(89)92133-5","article-title":"Preliminary biochemical characterization of two angiotensin II receptor subtypes","volume":"163","author":"Whitebread","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib413","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0705448","article-title":"Angiotensin AT2 receptors: cardiovascular hope or hype?","volume":"140","author":"Widdop","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib414","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.HYP.0000033224.99806.8A","article-title":"AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade","volume":"40","author":"Widdop","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib415","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1440-1681.2008.04883.x","article-title":"Vascular angiotensin AT2 receptors in hypertension and ageing","volume":"35","author":"Widdop","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib416","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000037979.53963.8F","article-title":"AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1\u20137) on the endothelium","volume":"40","author":"Wiemer","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib417","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008129","article-title":"Diabetes and retinal vascular disorders: role of the reninangiotensin system","volume":"6","author":"Wilkinson-Berka","year":"2004","journal-title":"Exp Rev Mol Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib418","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/frne.1995.1002","article-title":"The angiotensin IV system: functional implications","volume":"16","author":"Wright","year":"1995","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib419","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0361-9230(93)90297-O","article-title":"Angiotensin II(3\u20138) (ANG IV) hippocampal binding: potential role in the facilitation of memory","volume":"32","author":"Wright","year":"1993","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib420","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.19-10-03952.1999","article-title":"Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning","volume":"19","author":"Wright","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib421","doi-asserted-by":"crossref","first-page":"R725","DOI":"10.1152\/ajpregu.00326.2002","article-title":"Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats","volume":"284","author":"Wright","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib422","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.ATV.0000150662.51436.14","article-title":"Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein","volume":"25","author":"Wruck","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib423","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/hq0102.102277","article-title":"Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice","volume":"22","author":"Wu","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib424","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/hc4601.099404","article-title":"Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury","volume":"104","author":"Wu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib425","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib426","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/01.HYP.0000029095.23198.AD","article-title":"Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice","volume":"40","author":"Xu","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib427","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.HYP.33.6.1414","article-title":"AT2 receptor and vascular smooth muscle cell differentiation in vascular development","volume":"33","author":"Yamada","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib428","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib429","doi-asserted-by":"crossref","first-page":"H2179","DOI":"10.1152\/ajpheart.00361.2003","article-title":"Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice","volume":"285","author":"Yan","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib430","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.CIR.0000020014.14176.6D","article-title":"Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction","volume":"106","author":"Yang","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib431","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.HYP.0000244108.30909.27","article-title":"Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor","volume":"48","author":"Yayama","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib432","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.103.058420","article-title":"Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload","volume":"308","author":"Yayama","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib433","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.CIR.0000156503.62815.48","article-title":"High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats","volume":"111","author":"You","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib434","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib435","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.HYP.0000113628.94574.0f","article-title":"Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors","volume":"43","author":"Zhang","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib436","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1471-4159.2003.01719.x","article-title":"Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells","volume":"85","author":"Zhao","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib437","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/01.STR.0000217404.64352.d7","article-title":"AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats","volume":"37","author":"Zhou","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib438","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1523\/JNEUROSCI.18-02-00679.1998","article-title":"Angiotensin II type 2 receptor stimulation of neuronal delayed-rectifier potassium current involves phospholipase A2 and arachidonic acid","volume":"18","author":"Zhu","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib439","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1440-1681.2003.03942.x","article-title":"Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling","volume":"30","author":"Zhu","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib440","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00001756-200004270-00009","article-title":"Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats","volume":"11","author":"Zhu","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib441","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1111\/j.1440-1681.1996.tb03077.x","article-title":"Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature","volume":"3","author":"Zhuo","year":"1996","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib442","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.HYP.33.1.347","article-title":"Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney","volume":"33","author":"Zhuo","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib443","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.pharmtox.37.1.53","article-title":"Tissue renin\u2013angiotensin system: a site of drug action?","volume":"37","author":"Zimmerman","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib444","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","article-title":"Increased angiotensin-(1\u20137)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1369\/jhc.5C6782.2005","article-title":"Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques","volume":"54","author":"Zulli","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.pharmthera.2008.08.009_bib446","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.bjp.0702210","article-title":"Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors","volume":"125","author":"Zwart","year":"1998","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T19:36:13Z","timestamp":1738352173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725808001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":446,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0163725808001435"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2008.08.009","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}